Tourette's syndrome: a disorder of cingulate and orbitofrontal function?

We discuss the clinical characteristics of tics and Tourette's syndrome (TS) and also possible treatment options. Based upon an overview of published pathophysiological and PET data, and the results of a recent PET study of changes in opioid receptor binding in TS, we hypothesize that the disease arises due to dysfunction within the cingulate and orbitofrontal cortex. The beneficial effects of dopamine receptor antagonists and dopamine-depleting agents in TS are suggested to be mediated via basal ganglia-thalamofrontal circuits, while opioid agents may act directly on the cingulate.

[1]  J. Cummings,et al.  Frontal-subcortical circuits and human behavior. , 1993, Journal of psychosomatic research.

[2]  D. R. Weinberger,et al.  Cerebral morphometric abnormalities in Tourette's syndrome , 1995, Neurology.

[3]  H. Gurling,et al.  The genetic susceptibility to Gilles de la Tourette Syndrome in a large multiple affected british kindred: Linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase , 1995, Biological Psychiatry.

[4]  S. Rauch,et al.  Neurosurgical treatment of Tourette's syndrome: a critical review. , 1995, Comprehensive psychiatry.

[5]  B. Vogt,et al.  Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.

[6]  H. Singer,et al.  The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. , 1995, Pediatrics.

[7]  G. Sawle,et al.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[8]  C D Frith,et al.  Functional Anatomy of Obsessive–Compulsive Phenomena , 1994, British Journal of Psychiatry.

[9]  G. Erenberg,et al.  Sequential use of opioid antagonists and agonists In Tourette's syndrome , 1994, The Lancet.

[10]  J. Brotchie,et al.  On the Role of Enkephalin Cotransmission in the GABAergic Striatal Efferents to the Globus Pallidus , 1994, Experimental Neurology.

[11]  N. Alpert,et al.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.

[12]  C. McDougle,et al.  The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. , 1993, Journal of clinical psychopharmacology.

[13]  Richard S. J. Frackowiak,et al.  The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[14]  M. Nöthen,et al.  Tourette's syndrome and homozygosity for the dopamine D3 receptor gene , 1993, The Lancet.

[15]  D. Cohen,et al.  Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: A pilot study , 1993, Psychiatry Research.

[16]  H. Gurling,et al.  Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette's syndrome , 1993, The Lancet.

[17]  D. Weinberger,et al.  Age-Related Prognostic Factors in the Severity of Illness of Tourette's Syndrome in Monozygotic Twins , 1993 .

[18]  E. Chee,et al.  Volumetric MRI changes in basal ganglia of children with Tourette's syndrome , 1993, Neurology.

[19]  B. Peterson,et al.  Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images , 1993, Neurology.

[20]  D. Comings,et al.  Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene , 1993, The Lancet.

[21]  T. Jones,et al.  Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  D. E. Walker,et al.  Premonitory urges in Tourette's syndrome. , 1993, The American journal of psychiatry.

[23]  S. Haber,et al.  Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study. , 1992, Advances in neurology.

[24]  H. Singer,et al.  Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome. , 1992, Advances in neurology.

[25]  J. Rapoport,et al.  Tourette syndrome and obsessive-compulsive disorder. , 1992, Advances in neurology.

[26]  B. Levin,et al.  Childhood obsessive-compulsive disorder and cingulate epilepsy , 1991, Biological Psychiatry.

[27]  H. Singer,et al.  Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.

[28]  G. S. Mudholkar,et al.  A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome , 1991, Annals of neurology.

[29]  M. Jenike,et al.  Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. , 1991, Archives of general psychiatry.

[30]  H. Singer,et al.  Tourette Syndrome and Other Tic Disorders Diagnosis, Pathophysiology, and Treatment , 1991, Medicine.

[31]  R. Kurlan,et al.  Opiate therapy and self‐harming behavior in tourette's syndrome , 1991, Movement disorders : official journal of the Movement Disorder Society.

[32]  M. Trimble,et al.  The treatment of Gilles de la Tourette syndrome by limbic leucotomy. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[33]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[34]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[35]  M. Robertson.  The Gilles de la Tourette Syndrome: the Current Status , 1989, British Journal of Psychiatry.

[36]  W. Goodman,et al.  Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. , 1989, Archives of general psychiatry.

[37]  J. Miller,et al.  Motor Areas of the Cerebral Cortex. CIBA Foundation Symposium 132. , 1988 .

[38]  E. Caine,et al.  Tourette's syndrome in Monroe County school children , 1988, Neurology.

[39]  T. Feinberg,et al.  Gilles de la Tourette syndrome, 2nd ed. , 1988 .

[40]  C. Nemeroff,et al.  Elevated CSF dynorphin A [1-8] in Tourette's syndrome. , 1988, Life sciences.

[41]  D L Rosene,et al.  Cingulate cortex of the rhesus monkey: I. Cytoarchitecture and thalamic afferents , 1987, The Journal of comparative neurology.

[42]  D. Pandya,et al.  Cingulate cortex of the rhesus monkey: II. Cortical afferents , 1987, The Journal of comparative neurology.

[43]  Goldman-Rakic Ps,et al.  Motor control function of the prefrontal cortex. , 1987 .

[44]  P. Goldman-Rakic.  Motor control function of the prefrontal cortex. , 1987, Ciba Foundation symposium.

[45]  D. Cohen,et al.  Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. , 1986, Archives of general psychiatry.

[46]  M. Shafii.  The effects of sympathomimetic and antihistaminic agents on chronic motor tics and Tourette's disorder. , 1986, The New England journal of medicine.

[47]  J. Biederman,et al.  A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. , 1986, The Journal of clinical psychiatry.

[48]  Suzanne N. Haber,et al.  Gilles de la Tourette's syndrome A postmortem neuropathological and immunohistochemical study , 1986, Journal of the Neurological Sciences.

[49]  P. Max,et al.  Tourette's syndrome and attention deficit disorder. , 1986 .

[50]  W. Fisher,et al.  Prevalence of Gilles de la Tourette's syndrome in North Dakota adults. , 1986, The American journal of psychiatry.

[51]  D. Benson,et al.  Obsessions and compulsions in Gilles de la Tourette's syndrome , 1986, Neurology.

[52]  T. Chase,et al.  Structural and functional studies of Gilles de la Tourette syndrome. , 1986, Revue neurologique.

[53]  W. Licamele,et al.  Tourette's syndrome and attention deficit disorder. , 1986, The Journal of clinical psychiatry.

[54]  R. D. Hunt,et al.  Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. , 1985, Journal of the American Academy of Child Psychiatry.

[55]  K. Kidd,et al.  A twin study of Tourette syndrome. , 1985, Archives of general psychiatry.

[56]  W. Matthews,et al.  Disorders of arousal in Gilles de la Tourette's syndrome , 1984, Neurology.

[57]  J. Frost,et al.  Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome , 1984, Neurology.

[58]  R. Bruun.  An Overview of Clinical Experience , 1984 .

[59]  M. Trimble,et al.  A clinical study of Gilles de la Tourette syndrome in the United Kingdom. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[60]  R. Bruun.  Gilles de la Tourette's syndrome. An overview of clinical experience. , 1984, Journal of the American Academy of Child Psychiatry.

[61]  J. Lakke,et al.  Gilles de la Tourette syndrome , 2017, Nature Reviews Disease Primers.

[62]  O. Devinsky.  Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. , 1983, Archives of neurology.

[63]  S. Pulst,et al.  Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. , 1983, Archives of neurology.

[64]  J. Waserman,et al.  Gilles de la Tourette's syndrome in monozygotic twins , 1983, Journal of neurology, neurosurgery, and psychiatry.

[65]  C. Tanner,et al.  Cholinergic mechanisms in Tourette syndrome , 1982, Neurology.

[66]  J. Coyle,et al.  Dopaminergic dysfunction in tourette syndrome , 1982 .

[67]  Bonnet Ka.  Neurobiological dissection of Tourette syndrome: a neurochemical focus on a human neuroanatomical model. , 1982 .

[68]  Richardson Ep.  Neuropathological studies of Tourette syndrome. , 1982 .

[69]  Sack Ow.  Acquired Tourettism in adult life. , 1982 .

[70]  S. Fahn.  A case of post-traumatic tic syndrome. , 1982, Advances in neurology.

[71]  O. Sacks.  Acquired Tourettism in adult life. , 1982, Advances in neurology.

[72]  Neurobiological dissection of Tourette syndrome: a neurochemical focus on a human neuroanatomical model. , 1982, Advances in neurology.

[73]  C. Ludlow,et al.  Language and speech abnormalities in Tourette syndrome. , 1982, Advances in neurology.

[74]  E. Richardson.  Neuropathological studies of Tourette syndrome. , 1982, Advances in neurology.

[75]  U. Jürgens,et al.  On the neural control of mammalian vocalization , 1981, Trends in Neurosciences.

[76]  F. Gray,et al.  Bilateral infarction of the anterior cingulate gyri and of the fornices Report of a case , 1981, Journal of the Neurological Sciences.

[77]  M. Chesselet,et al.  Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus , 1981, Nature.

[78]  B. Shaywitz,et al.  Clonidine ameliorates Gilles de la Tourette syndrome. , 1980, Archives of general psychiatry.

[79]  M. Åsberg,et al.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[80]  Stahl Sm.  Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration. , 1980 .

[81]  W. Mendelson,et al.  Sleep in Gilles de la Tourette syndrome. , 1980, Biological psychiatry.

[82]  S. Stahl.  Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration. , 1980, The American journal of psychiatry.

[83]  W. Nauta,et al.  Efferent connections of the substantia nigra and ventral tegmental area in the rat , 1979, Brain Research.

[84]  C. Crosley.  Decreased serotoninergic activity in tourette syndrome , 1979, Annals of neurology.

[85]  U. Jürgens,et al.  Role of the periaqueductal grey in vocal expression of emotion , 1979, Brain Research.

[86]  W. Weiner,et al.  Gilles de la Tourette syndrome after long‐term chlorpromazine therapy , 1978, Neurology.

[87]  B. Shaywitz,et al.  Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. , 1978, Archives of general psychiatry.

[88]  A. Barbeau,et al.  Seven Cases of Gilles de la Tourette's Syndrome: Partial Relief with Clonazepam: A Pilot Study , 1977, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[89]  A. F. Guardiola,et al.  Chronic stimulation of the cingulum in humans with behavior disorders , 1973 .

[90]  J. Talairach,et al.  The cingulate gyrus and human behaviour. , 1973, Electroencephalography and clinical neurophysiology.

[91]  G. Mazars.  Criteria for Identifying Cingulate Epilepsies* , 1970, Epilepsia.

[92]  Nielsen Jm,et al.  Bilateral anterior cingulate gyrus lesions; report of case. , 1953 .

[93]  R W BARRIS,et al.  Bilateral Anterior Cingulate Gyrus Lesions , 1953, Neurology.